iRhythm Technologies' Chief Commercial Officer Sells 2,555 Shares

iRhythm Technologies, Inc. (IRTC) has disclosed that its Chief Commercial Officer, Chad Patterson, has recently disposed of 2,555 shares of the company's stock at a price of $158.97 per share on August 6, 2025.

iRhythm Technologies, Inc. (IRTC) has disclosed that its Chief Commercial Officer, Chad Patterson, recently sold 2,555 shares of the company's stock on August 6, 2025, at a price of $158.97 per share. This transaction was part of a single open-market sale that occurred on the same date.

The sale represents a significant portion of Patterson's direct holdings, with the transaction reducing his direct ownership to 46,222 shares. Prior to the sale, Patterson held approximately 5.5% of his shares in the company. The sale was reported solely to satisfy tax-withholding obligations triggered by the vesting of previously granted restricted stock units (RSUs) [1].

While insider sales can sometimes signal a cooling sentiment, the stated tax-withholding motive and Patterson's remaining sizable stake suggest that the impact on the broader investment thesis is limited and largely administrative. No derivative transactions, option exercises, or additional purchases were reported, and the filing does not mention any 10b5-1 trading plan [1].

In addition to the insider sale, iRhythm Technologies, Inc. (IRTC) reported strong second-quarter results, with revenue increasing by 26.1% year-over-year to $186.7 million. The company also expanded its adjusted EBITDA margins by 500 basis points since the previous year, demonstrating sustainable operating leverage. However, the company continues to face incremental legal and consulting fees related to FDA remediation efforts and DOJ subpoena activities, which could impact gross margins [2].

References:

[1] https://www.stocktitan.net/sec-filings/IRTC/form-4-i-rhythm-technologies-inc-insider-trading-activity-49c010f3996c.html
[2] https://finance.yahoo.com/news/irhythm-technologies-inc-irtc-q2-073713971.html